PROFUND ADVISORS LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in RLAY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,653,421

+$975,130 QoQ

Shares Held

88,371

+29.6% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#114

of 256 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. RLAY ranks #34 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,653,421	88,371	+29.6%	Shares	Sole	2026-08-11
2026-03-31	$678,291	68,170	-6.1%	Shares	Sole	2026-04-27
2025-12-31	$614,077	72,586	+115.4%	Shares	Sole	2026-02-06
2025-09-30	$175,914	33,700	-12.7%	Shares	Sole	2025-11-06
2025-06-30	$133,635	38,623	-10.0%	Shares	Sole	2025-08-07
2025-03-31	$112,473	42,929	-11.6%	Shares	Sole	2025-05-08
2024-12-31	$199,980	48,539	+34.3%	Shares	Sole	2025-02-14
2024-09-30	$255,821	36,133	-0.8%	Shares	Sole	2024-11-14
2024-06-30	$237,445	36,418	-49.7%	Shares	Sole	2024-08-13
2024-03-31	$600,496	72,349	+33.9%	Shares	Sole	2024-05-08
2023-12-31	$594,859	54,029	-15.5%	Shares	Sole	2024-02-14
2023-09-30	$537,659	63,931	-43.5%	Shares	Sole	2023-11-13
2023-06-30	$1,420,699	113,113	+37.4%	Shares	Sole	2023-08-10
2023-03-31	$1,355,662	82,311	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.